Microfluidic Device System
Market
Microfluidic Device System Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Microfluidic Device System Market Size and Growth
The global microfluidic device system market is expected to reach a value of $8.7 billion by 2026, with a CAGR of 18.3% from 2021 to 2026. Factors driving market growth include increasing demand for point-of-care diagnostics and drug development, particularly in the pharmaceutical and biotechnology industries.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Roche Diagnostics
◍ Abbott Laboratories
◍ Siemens Healthcare
◍ Agilent Technologies
◍ Fluidigm
◍ Bio- Rad Laboratories
◍ Cepheid
◍ RainDance Technologies
◍ Dolomite Centre
◍ Micronit Microfluidics
◍ Johnson & Johnson
◍ Becton, Dickinson and Company
The competitive landscape of the Microfluidic Device System Market includes Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Fluidigm, Bio-Rad Laboratories, Cepheid, RainDance Technologies, Dolomite Centre, Micronit Microfluidics, Johnson & Johnson, and Becton, Dickinson and Company.
These companies leverage microfluidic device systems for research, diagnostic testing, drug development, and personalized medicine, contributing to the growth of the market.
- Roche Diagnostics - Sales revenue: $14.79 billion. - Abbott Laboratories - Sales revenue: $31.9 billion. - Siemens Healthcare - Sales revenue: $14.2 billion. - Agilent Technologies - Sales revenue: $5.16 billion.
Request Sample Report
Market Segmentation
By Application
◍ Point of Care Testing
◍ Pharmaceutical and Life Science Research
◍ Drug Delivery
◍ Analytical Devices
◍ Clinical and Veterinary Diagnostics
◍ Environment and Industrial
By Product
Glass
Polymer
Silicon
Request Sample Report
◍
◍
◍
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients